Related Experiment Video
Updated: Apr 5, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Development and Evaluation of the New Predictive Models in Tuberculous Pleuritis
J Klimiuk1, A Safianowska2, R Chazan2
1Department of Internal Medicine, Pneumonology and Allergology, Medical University of Warsaw, 1A Banacha St., 02-097, Warsaw, Poland. askaklimiuk@wp.pl.
New models can help distinguish tuberculous pleural effusion (TPE) from non-TPE. These models use clinical data and pleural fluid biomarkers, excluding interferon gamma, for accurate diagnosis.
Area of Science:
- Pulmonology
- Infectious Diseases
- Biomarker Research
Background:
- Distinguishing tuberculous pleural effusion (TPE) from non-TPE is clinically important.
- Interferon gamma (IFN-γ) is a highly accurate biomarker but not always practical.
- Need for alternative diagnostic models for TPE.
Purpose of the Study:
- To develop predictive models for differentiating TPE from non-TPE.
- Models to utilize clinical data and pleural fluid biomarkers, excluding IFN-γ.
- Achieve high diagnostic accuracy comparable to existing methods.
Main Methods:
- Prospective enrollment of 242 patients with newly diagnosed pleural effusion.
- Measurement of pleural fluid biomarkers including ADA, IL-2, IL-18, IP-10, and TNF-α.
- Development of predictive models using ROC analysis and logistic regression.
Main Results:
- Two predictive models with AUC > 0.95 were developed.
- Model 1: body temperature, white blood cell count, pleural fluid ADA, and IP-10.
- Model 2: age, sex, body temperature, white blood cell count, lymphocyte percentage, and IP-10.
Conclusions:
- Developed models show very high diagnostic performance for TPE vs. non-TPE.
- These models can potentially be used in clinical practice.
- Provides valuable tools for differentiating pleural effusion types.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
